United States · FDA National Drug Code directory
Optiray 350
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0019-1333_471b67c4-92c2-de51-e063-6394a90ada6c
- Product NDC
- 0019-1333
- Form
- INJECTION
- Composition / generic term
- Ioversol
- Labeler
- Liebel-Flarsheim Company LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20111017
- Source listing expiry
- 20261231
Source-listed ingredients
- IOVERSOL — 741 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 BOTTLE, GLASS in 1 CARTON (0019-1333-51) / 250 mL in 1 BOTTLE, GLASS · 0019-1333-51
- 6 BOTTLE, GLASS in 1 CARTON (0019-1333-61) / 500 mL in 1 BOTTLE, GLASS · 0019-1333-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →